Cover Image
市場調查報告書

轉移性大腸癌:全球臨床實驗檢討

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 299738
出版日期 內容資訊 英文 239 Pages
訂單完成後即時交付
價格
Back to Top
轉移性大腸癌:全球臨床實驗檢討 Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月15日 內容資訊: 英文 239 Pages
簡介

本報告提供轉移性大腸癌相關臨床研究最新趨勢相關分析,以疾病概要為首,提供地區及主要國家的臨床實驗狀況,Phase別·各進展狀況臨床實驗資料,被實驗者的募集情況,有潛力的贊助商,並彙整各企業·研究機關臨床實驗簡介等資訊,為您概述為以下內容。

目錄

簡介

  • 轉移性大腸癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數和平均實驗人數
    • 亞太地區的主要5個國家
    • 歐洲的主要5個國家
    • 北美的主要國家
    • 中東非洲的主要5個國家
    • 中南美的主要5個國家

在G7各國臨床實驗

在G7各國臨床實驗:Phase別

在G7各國臨床實驗:各進展狀況

在E7各國臨床實驗

在E7各國臨床實驗:Phase別

在E7各國臨床實驗:各進展狀況

Phase別臨床實驗

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗

一定期間所採用的實驗對象

贊助商的不同種類的臨床實驗

有潛力的贊助商

  • 參加轉移性大腸癌症治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Sanofi
    • Pfizer Inc.
    • E. Merck KG
    • Eli Lilly and Company
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Bayer AG
    • AstraZeneca PLC
  • 有代表性的醫院·研究機關臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Grupo Espanol de Tratamiento de Tumores Digestivos
    • Epidemiological and Clinical Research Information Network
    • European Organization for Research and Treatment of Cancer
    • Gruppo Oncologico del Nord-Ovest
    • NCIC Clinical Trials Group
    • Duke University

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2085CTIDB

GlobalData's clinical trial report, "Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Colorectal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Colorectal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Colorectal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Metastatic Colorectal Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Metastatic Colorectal Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Metastatic Colorectal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Metastatic Colorectal Cancer
    • Apr 07, 2014: Immunomedics Reports Results From Three Phase I Trials With IMMU-130 in Metastatic Colorectal Cancer
    • Apr 06, 2014: MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting
    • Dec 02, 2013: AB Science announces initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer
    • Nov 28, 2013: Alchemia Provides an Update on Progress of HA-Irinotecan
    • Nov 11, 2013: Phase III Clinical Trial Results of TS-1 on Metastatic Colorectal Cancer Published in Digital Version of The Lancet Oncology
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Grupo Espanol de Tratamiento de Tumores Digestivos
      • Clinical Trial Overview of Grupo Espanol de Tratamiento de Tumores Digestivos
      • Epidemiological and Clinical Research Information Network
      • Clinical Trial Overview of Epidemiological and Clinical Research Information Network
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Gruppo Oncologico del Nord-Ovest
      • Clinical Trial Overview of Gruppo Oncologico del Nord-Ovest
      • NCIC Clinical Trials Group
      • Clinical Trial Overview of NCIC Clinical Trials Group
      • Duke University
      • Clinical Trial Overview of Duke University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Tratamiento de Tumores Digestivos, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Epidemiological and Clinical Research Information Network, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gruppo Oncologico del Nord-Ovest, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*

List of Figures

  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top